CClaimWatch
Claims closedsecurities

Masimo Securities Settlement

This settlement is closed to new claims — the deadline was April 28, 2026. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

Masimo Corporation allegedly made misleading statements or omissions regarding its publicly traded common stock. Shareholders claim they were damaged by purchasing or acquiring the stock during the class period.

Do you qualify?

All persons and entities who purchased or acquired publicly traded common stock of Masimo during the period from May 4, 2022, through August 8, 2023, and were allegedly damaged thereby.

How to file

Submit a claim form by April 28, 2026. The claim form can be filed online at the settlement website. You may call the helpline at (866) 830-0516 or email info@MasimoSecuritiesSettlement.com for more information.

Common questions

What is the claim deadline for the Masimo Securities Settlement?
This settlement is closed to new claims — the deadline was April 28, 2026. Once a claim deadline passes you generally forfeit your share, even if you qualified.
Is the Masimo Securities Settlement notice real, or a scam?
Claims are filed at masimosecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
When will payments from the Masimo Securities Settlement be sent?
Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for May 11, 2026; no payments can be issued before a settlement receives final approval.

In the news

Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.

New to class actions?

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

More securities settlements

View all →
August 28, 2026securities

Revance Securities Settlement

Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.

Not yet determinable; depends on number of valid claims submitted

September 24, 2026securities

Biogen Securities Litigation Settlement

Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.

October 6, 2026securities

NJ Bureau of Securities Settlement with Credit Suisse

Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.

October 7, 2026securities

Stitch Fix Securities Litigation Settlement

Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.